We are live on
!
Find out more
VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Est. Return
24.67%
This Fund
S&P 500
This Quarter
Est. Return
-0.3%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$752M
AUM Growth
+$253M
(+51%)
Cap. Flow
+$268M
Cap. Flow
% of AUM
35.64%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
1,082
New
405
Increased
619
Reduced
41
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$17.4M |
| 2 |
Apple
AAPL
|
+$7.52M |
| 3 |
Broadcom
AVGO
|
+$6.81M |
| 4 |
Bausch Health
BHC
|
+$5.93M |
| 5 |
NBIS
Nebius Group N.V.
NBIS
|
+$4.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$2.86M |
| 2 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
+$1.98M |
| 3 |
EGLE
Eagle Bulk Shipping Inc.
EGLE
|
+$1.84M |
| 4 |
ALTR
Altera Corp
ALTR
|
+$1.74M |
| 5 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.2% |
| 2 | Healthcare | 13.08% |
| 3 | Industrials | 11.83% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHI
776
DELISTED
Baker Hughes
BHI
| $54K | 0.01% |
+869
| New | +$56.8K |
|
777
Coca-Cola Europacific Partners
CCEP
$47.9B
| $53K | 0.01% |
+1,218
| New | +$54.6K |
|
778
Freeport-McMoran
FCX
$97.5B
| $53K | 0.01% |
+2,850
| New | +$58.8K |
|
779
Loews
L
$23.6B
| $53K | 0.01% |
+1,370
| New | +$55.7K |
|
780
NRG Energy
NRG
$24.8B
| $53K | 0.01% |
+2,313
| New | +$57.8K |
|
|
LLL
781
DELISTED
L3 Technologies, Inc.
LLL
| $52K | 0.01% |
+462
| New | +$55K |
|
782
NetApp
NTAP
$37.2B
| $51K | 0.01% |
+1,626
| New | +$56.4K |
|
783
Southern Company
SO
$107B
| $51K | 0.01% |
+1,211
| New | +$52.8K |
|
784
Conagra Brands
CAG
$7.23B
| $50K | 0.01% |
+1,474
| New | +$44.3K |
|
785
CenterPoint Energy
CNP
$26.8B
| $50K | 0.01% |
+2,625
| New | +$53.1K |
|
786
Ford
F
$55.7B
| $50K | 0.01% |
+3,330
| New | +$51.6K |
|
|
PPL
787
PPL Corp
PPL
$26.7B
| $50K | 0.01% |
+1,681
| New | +$52.5K |
|
788
Corning
GLW
$143B
| $48K | 0.01% |
+2,414
| New | +$51.6K |
|
789
Perrigo
PRGO
$1.78B
| $46K | 0.01% |
+249
| New | +$47.5K |
|
790
Gilead Sciences
GILD
$165B
| $45K | 0.01% |
+384
| New | +$42K |
|
791
Hasbro
HAS
$13.2B
| $45K | 0.01% |
+603
| New | +$43K |
|
792
Xerox
XRX
$425M
| $44K | 0.01% |
+1,580
| New | +$48.9K |
|
|
ALTR
793
DELISTED
Altera Corp
ALTR
| $44K | 0.01% |
855
-37,257
| -98% | -$1.74M |
|
794
Ventas
VTR
$47.9B
| $41K | 0.01% |
+576
| New | +$45K |
|
795
Cigna
CI
$74.6B
| $38K | 0.01% |
+235
| New | +$32.5K |
|
|
PLL
796
DELISTED
PALL CORP
PLL
| $38K | 0.01% |
+303
| New | +$34.2K |
|
|
BRCM
797
DELISTED
BROADCOM CORP CL-A
BRCM
| $36K | ﹤0.01% |
+697
| New | +$33.9K |
|
798
Crown Castle
CCI
$32.2B
| $35K | ﹤0.01% |
+433
| New | +$36.1K |
|
799
Clorox
CLX
$12.7B
| $35K | ﹤0.01% |
+336
| New | +$36.3K |
|
|
EA
800
DELISTED
Electronic Arts
EA
| $35K | ﹤0.01% |
+527
| New | +$32.4K |
|
Similar funds
EST
TCM
AWS
WI
JP
VCM
FCB
FCFS
Vident Investment Advisory's Q2 2015 Portfolio in Review
As of Q2 2015, Vident Investment Advisory held 1,082 positions worth $752M, up 51% from $498M the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Vident Investment Advisory deployed $268M of net new capital in Q2 2015, opening 405 new positions and adding to 619 existing holdings. Its largest new stake was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $2.86M trimmed.
- Vident Investment Advisory's largest Q2 2015 buy was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.
- Vident Investment Advisory added most to Apple in Q2 2015, an estimated $7.52M increase.
- Vident Investment Advisory's biggest Q2 2015 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $2.86M.
- Vident Investment Advisory fully exited AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2015, selling an estimated $1.98M.
- Vident Investment Advisory's ten largest holdings make up 9.6% of its $752M portfolio in Q2 2015.
- Vident Investment Advisory opened 405 new positions and closed 17 in Q2 2015.
- Vident Investment Advisory's portfolio value rose 51% quarter-over-quarter to $752M.
Based on Vident Investment Advisory's 13F filing for Q2 2015, filed 29 Jul 2015.